MRK and BMY Related Headlines
Go Back- Barclays launches U.S. biopharma coverage with four preferred picks
- 14 of 17 Leading Drug Manufactures Now Part of Trump Most Favored Nation Efforts
- Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now
- Bernstein on AmericasMedicines.com: 'The Noise Starts, But Not (Yet) from Trump'
- Raymond James Comments on FDA and HHS Reforms for DTC Pharma Advertising
- REPAY names Robert Houser as chief financial officer
- Trump demands pharma CEOs lower drug prices within 60 days
- Trump Posts Letters to Regeneron, Merck, AstraZeneca, GSK, Pfizer, Novo Nordisk, Amgen, Bristol-Myears, AbbVie, Novartis, Gilead, J&J on Truth Social
